ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 004

Barriers and Facilitators to Teratogenicity Knowledge and Application among Adolescents and Young Adults with Rheumatic Disease

Brittany Huynh1, Elizabeth Pfeiffer2 and Stacey Tarvin3, 1University of Alabama at Birmingham, 2Rhode Island College, 3Riley Hospital for Children at Indiana University, Indianapolis, IN

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Plenary Abstract Session I

Session Time: 3:15PM-3:30PM

Background/Purpose: Prior studies demonstrate low levels of teratogenicity knowledge among adolescents and young adults (AYAs) with rheumatic disease. This study sought to describe barriers and facilitators to teratogenicity knowledge and its application to their reproductive lives.

Methods: In 2024, AYAs age 14-21 years, assigned female at birth, with a rheumatic disease, and taking teratogenic medications were recruited from pediatric rheumatology clinics in Indiana to participate in semi structured interviews to assess barriers and facilitators influencing teratogenicity knowledge and its application. Interviews were recorded and transcribed by a professional service. Data were analyzed in Dedoose by two of the authors (BH, EP) who engaged in inductive initial coding to identify themes from the data, resolving differences through discussions until theoretical saturation was reached. After identifying key themes and creating a codebook, categories were developed through exploration of how key concepts fit together. Analysis proceeded using constant comparison analysis, the standard analysis technique utilized in grounded theory as described by Charmaz (2014). Hypothesized relationships among categories were explored through reexamination of the data using an iterative approach. We then reanalyzed the transcripts to perform a priori coding to develop and confirm our theoretical framework.

Results: 21 AYAs with a variety of rheumatic diseases participated in interviews (background characteristics in Table 1). Participants were on average 16.3 years old. 33% were sexually experienced and 38% on birth control. 29% had teratogenicity knowledge and 33% had limited knowledge. 43% reported teratogenicity counseling.
Some reporting counseling had limited understanding of teratogenicity or its application to their lives. Most participants connected importance to future planned pregnancies. Many did not acknowledge risk of unintended pregnancy or consideration of contraception at time of interview or in the future.
Barriers to teratogenicity knowledge despite counseling fell into 3 categories: disease or medication factors overshadowing teratogenicity; perceived irrelevance of information at time of counseling due to abstinence or desire to remain child-free; and hesitation to ask questions or engage in discussion with providers due to reproductive health issues being perceived as awkward/taboo, parental presence, or strategic avoidance.Facilitators included personal or social network with medical knowledge from training or lived experience, detailed and repeated teratogenicity counseling, and open reproductive health conversations with those in social networks. (Table 2)

Conclusion: Identified barriers and facilitators reveal opportunities to facilitate AYA understanding of teratogenicity’s effect on their reproductive lives. This includes highlighting reproductive health considerations after sexual debut, repeat counseling to capture AYAs when information is perceived to apply to their lives, and alone time with provider to promote open discussion regarding teratogenicity and reproductive health considerations.
Charmaz, K. (2014). Constructing grounded theory (2nd ed.). Sage. 

Table 1. Participant CharacteristicsSupporting image 1

Table 2. Representative quotes from adolescents and young adults (AYAs) regarding barriers and facilitators to teratogenicity knowledge and application to their reproductive livesSupporting image 2


Disclosures: B. Huynh: None; E. Pfeiffer: None; S. Tarvin: AbbVie/Abbott, 5, Amgen, 5, Roche, 5, UCB, 5.

To cite this abstract in AMA style:

Huynh B, Pfeiffer E, Tarvin S. Barriers and Facilitators to Teratogenicity Knowledge and Application among Adolescents and Young Adults with Rheumatic Disease [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/barriers-and-facilitators-to-teratogenicity-knowledge-and-application-among-adolescents-and-young-adults-with-rheumatic-disease/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/barriers-and-facilitators-to-teratogenicity-knowledge-and-application-among-adolescents-and-young-adults-with-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology